Single-Step, Label-Free, Highly Accurate Analyte Detection

Description

This technology is two cutting-edge systems for single-step, label-free detection of analytes such as nucleic acids and certain drugs, particularly when the analyte exists in extremely low concentrations potentially replacing complex and expensive techniques such as qT-PCR.

The first system is a novel electrochemical method for simultaneous detection and quantification of multiple microRNAs as disease biomarkers within minutes.  This sensor technology avoids time-consuming and labor-intensive sample pretreatments and complicated multi-step analysis procedures.  It can be used as a high-throughput, point-of-care diagnostic tool. Currently used PCR tests can take hours to days for quantitative lab results or only provide yes/no answers in a shorter timeframe. The shorter tests have a high rate of false positive results.

The second system is an innovative electrochemiluminescence technique with a high signal/noise ratio and high specificity toward the chosen target analyte.  It could be applied to directly detect compounds for which antibody/enzymes detection systems are not yet available, and as a readout system for assay/sensor development and drug development.  The system is rapid, simple, and allows for sensitive and specific detection of analytes of interest at a low cost.

 

Benefits

  • Simple, Rapid & Low Cost –single-step and label-free platforms for detection in minutes, avoiding time-consuming and labor-intensive processing
  • Accurate highly sensitive and specific, with minimal interference, for detecting a variety of analytes at very low sample concentrations
  • Flexible adaptable design for diagnosing a variety of diseases or detection of compounds that currently lack detection reagents.

 

Applications

  • Point-of-care diagnostic devices
  • Diagnostic tools for cancer and other diseases
  • Research tools for studying gene expression and regulation
  • Monitoring of therapeutic drugs for personal medicine
  • Forensic applications for genetic material identification
  • Drug discovery and high-throughput screening

 

Patent Status

Publications

T. Wang, et. al. (2015). Analytical Chemistry, 87(16), 8173-8180.

S. Chen, et. al. (2019). Journal of the American Chemical Society, 141(24), 9603-9609.

T. Wang, et. al. (2016). Journal of the American Chemical Society, 138, 6380-6383.

T. Wang, et. al. (2017). ChemElectroChem, 4(7), 1697-1701.

2018_Metal ions-modulated near-infrared electrochemiluminescence from Au nanoclusters enhanced by 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid at physiological pH - ScienceDirect

Ma, H.; Yi, M.; Messinger, M.; Wang, G., Kinetics-Based Ratiometric Electrochemiluminescence Analysis for Signal Specificity: Case Studies of Piperazine Drug Discrimination with Au Nanoclusters. Anal. Chem. 2022, 94 (34), 11760-11766.

Electrocatalytic Effects of Au Nanoclusters in its Electrochemiluminescence Enhanced by Coreactant Tertiary Amines - Ma - 2024 - ChemElectroChem - Wiley Online Library

Patent Information: